Pub Date : 2025-12-26DOI: 10.1186/s41182-025-00886-3
Min Wu, Man Liu, Yating Cao, Chanjuan Ye, Qian Qu, Yuanyuan Zheng, Shaowu Chen
Background: Periodontal disease substantially affects women's quality of life and shows sex-specific patterns due to physiological characteristics such as hormonal fluctuations, pregnancy, and menopause. However, most global assessments have focused on the general population and have not systematically characterized age specific burdens among women across different socio-demographic settings. This study addresses this gap by providing a life course analysis of the global, regional, and national incidence of periodontal disease in females from 1990 to 2021.
Methods: Within the Global Burden of Disease (GBD) framework, we estimated female incidence and age-standardized rates (ASR) of periodontal disease across the life course in 204 countries and territories. Socio-Demographic Index (SDI)-incorporating per-capita income, years of schooling, and fertility in women under 25-was used to stratify locations into five levels (low, low-middle, middle, high-middle, high). We examined incidence trends and burden in eight specific physiological stages (childhood, adolescent, reproductive-age, prime reproductive-age, adult, perimenopausal, menopausal and older-age), and assessed the effects of oral health resources, diagnostic rates, and hormonal fluctuations. Our study presented point estimates with 95% confidence intervals (CIs). It evaluated the changing trends in the burden of Periodontal Disease using the estimated annual percentage change (EAPC) and percentage change.
Results: Globally, the ASR differed across stages and was generally higher from the optimal reproductive age through older age. From 1990 to 2021, ASR rose steadily in childhood and adolescence, with a notable increase during the reproductive age in 2010-2014 (APC = 2.14). The optimal reproductive age showed increases in 1998-2005 and 2010-2014, adulthood and perimenopause exhibited fluctuating upward trends, while menopause and older age displayed divergent patterns. ASR-SDI associations were stage-dependent: negative correlations in childhood and adolescence, no significant association in adulthood and reproductive age, positive correlations in mid- to late-life, and SDI threshold effects (around SDI = 0.5, ASR tends to decrease; around SDI = 0.8, decelerated ASR growth).
Conclusions: Policymakers should tailor public health strategies to high-burden regions and key life stages (e.g., reproductive and mid-to-late life), expand oral-health investment for children and adolescents in low-SDI areas, and strengthen screening/interventions for mid-older women in high-SDI regions.
{"title":"Exploring the age-dependent burden of periodontal disease in women across different socio-demographic levels.","authors":"Min Wu, Man Liu, Yating Cao, Chanjuan Ye, Qian Qu, Yuanyuan Zheng, Shaowu Chen","doi":"10.1186/s41182-025-00886-3","DOIUrl":"10.1186/s41182-025-00886-3","url":null,"abstract":"<p><strong>Background: </strong>Periodontal disease substantially affects women's quality of life and shows sex-specific patterns due to physiological characteristics such as hormonal fluctuations, pregnancy, and menopause. However, most global assessments have focused on the general population and have not systematically characterized age specific burdens among women across different socio-demographic settings. This study addresses this gap by providing a life course analysis of the global, regional, and national incidence of periodontal disease in females from 1990 to 2021.</p><p><strong>Methods: </strong>Within the Global Burden of Disease (GBD) framework, we estimated female incidence and age-standardized rates (ASR) of periodontal disease across the life course in 204 countries and territories. Socio-Demographic Index (SDI)-incorporating per-capita income, years of schooling, and fertility in women under 25-was used to stratify locations into five levels (low, low-middle, middle, high-middle, high). We examined incidence trends and burden in eight specific physiological stages (childhood, adolescent, reproductive-age, prime reproductive-age, adult, perimenopausal, menopausal and older-age), and assessed the effects of oral health resources, diagnostic rates, and hormonal fluctuations. Our study presented point estimates with 95% confidence intervals (CIs). It evaluated the changing trends in the burden of Periodontal Disease using the estimated annual percentage change (EAPC) and percentage change.</p><p><strong>Results: </strong>Globally, the ASR differed across stages and was generally higher from the optimal reproductive age through older age. From 1990 to 2021, ASR rose steadily in childhood and adolescence, with a notable increase during the reproductive age in 2010-2014 (APC = 2.14). The optimal reproductive age showed increases in 1998-2005 and 2010-2014, adulthood and perimenopause exhibited fluctuating upward trends, while menopause and older age displayed divergent patterns. ASR-SDI associations were stage-dependent: negative correlations in childhood and adolescence, no significant association in adulthood and reproductive age, positive correlations in mid- to late-life, and SDI threshold effects (around SDI = 0.5, ASR tends to decrease; around SDI = 0.8, decelerated ASR growth).</p><p><strong>Conclusions: </strong>Policymakers should tailor public health strategies to high-burden regions and key life stages (e.g., reproductive and mid-to-late life), expand oral-health investment for children and adolescents in low-SDI areas, and strengthen screening/interventions for mid-older women in high-SDI regions.</p>","PeriodicalId":23311,"journal":{"name":"Tropical Medicine and Health","volume":" ","pages":"14"},"PeriodicalIF":3.5,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12805735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145844387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-25DOI: 10.1186/s41182-025-00856-9
Saadaq Adan Hussein, Marian Muse Osman, Mohamed Mohamoud Hassan, Yahye Sheikh Abdulle Hassan, Abdirahman Aden Hussein, Rage Adem, Mohamed M Ali Fuje, Abdinur Hussein Mohamed, Ayan Nur Ali, Khadar Hussein Mohamud, Abdirahman Moallim Ibrahim, AbdulJalil Abdullahi Ali
Introduction: Somalia, one of the world's most climate-vulnerable nations despite contributing minimally to global emissions, is facing escalating public health crises due to climate change. Rising temperatures, erratic rainfall, recurrent droughts, and floods have intensified food insecurity, disease outbreaks, and population displacement. These changes have compounded existing challenges in a fragile health system, severely affecting children, pregnant women, and internally displaced persons Internally displaced people (IDP). This scoping review aims to map the extent and scope of published evidence on the prolonged public health impacts of climate change in Somalia, identifying key health outcomes, vulnerable populations, and research and policy gaps.
Methods: Following the PRISMA-ScR guidelines, a comprehensive search was conducted in PubMed, Scopus, Web of Science, and Google Scholar, as well as gray literature from WHO, UN agencies, and Somali institutions. Studies published between 1990 and 2025 in English and addressing the intersection of climate change and public health in Somalia or the Horn of Africa were included. Data were charted and synthesized thematically.
Results: Out of 379 retrieved articles, 142 met the inclusion criteria. Key themes emerged: (1) direct health impacts of climate change, (2) indirect health impacts, (3) vulnerable populations, (4) weak health infrastructure and system readiness, and (5) historical droughts and their cumulative health impacts. Children under five, pregnant women, and displaced persons are disproportionately affected. The review highlights significant evidence gaps in mental health, health system resilience, and early warning systems.
Conclusion: This scoping review highlights the severe and multifaceted public health impacts of climate change in Somalia, the fragile healthcare infrastructure in Somalia, and a heavy reliance on external aid. This review provides a foundation for future efforts to mitigate the public health impacts of climate change and build resilience in Somalia and similar vulnerable regions.
导言:索马里是世界上最易受气候影响的国家之一,尽管对全球排放的贡献最小,但由于气候变化,它正面临不断升级的公共卫生危机。气温上升、降雨不稳定、经常性干旱和洪水加剧了粮食不安全、疾病暴发和人口流离失所。这些变化使脆弱的卫生系统面临的挑战更加复杂,严重影响到儿童、孕妇和国内流离失所者。这次范围审查的目的是绘制关于气候变化对索马里长期公共卫生影响的已发表证据的程度和范围,确定主要卫生结果、弱势群体以及研究和政策差距。方法:根据PRISMA-ScR指南,在PubMed、Scopus、Web of Science和谷歌Scholar以及来自WHO、联合国机构和索马里机构的灰色文献中进行全面检索。其中包括1990年至2025年期间以英文发表的研究报告,涉及索马里或非洲之角气候变化与公共卫生的交叉问题。数据被绘制成图表并按主题合成。结果:379篇检索文献中,142篇符合纳入标准。关键主题包括:(1)气候变化对健康的直接影响;(2)间接影响;(3)弱势群体;(4)卫生基础设施和系统准备不足;(5)历史干旱及其累积健康影响。五岁以下儿童、孕妇和流离失所者受到的影响尤为严重。该审查强调了精神卫生、卫生系统复原力和早期预警系统方面的重大证据差距。结论:这一范围审查强调了气候变化对索马里公共卫生的严重和多方面的影响,索马里脆弱的医疗基础设施,以及对外援的严重依赖。这一审查为今后在索马里和类似脆弱地区减轻气候变化对公共卫生的影响和建立抵御能力奠定了基础。
{"title":"The prolonged devastation of climate change on public health in Somalia: a silent crisis.","authors":"Saadaq Adan Hussein, Marian Muse Osman, Mohamed Mohamoud Hassan, Yahye Sheikh Abdulle Hassan, Abdirahman Aden Hussein, Rage Adem, Mohamed M Ali Fuje, Abdinur Hussein Mohamed, Ayan Nur Ali, Khadar Hussein Mohamud, Abdirahman Moallim Ibrahim, AbdulJalil Abdullahi Ali","doi":"10.1186/s41182-025-00856-9","DOIUrl":"10.1186/s41182-025-00856-9","url":null,"abstract":"<p><strong>Introduction: </strong>Somalia, one of the world's most climate-vulnerable nations despite contributing minimally to global emissions, is facing escalating public health crises due to climate change. Rising temperatures, erratic rainfall, recurrent droughts, and floods have intensified food insecurity, disease outbreaks, and population displacement. These changes have compounded existing challenges in a fragile health system, severely affecting children, pregnant women, and internally displaced persons Internally displaced people (IDP). This scoping review aims to map the extent and scope of published evidence on the prolonged public health impacts of climate change in Somalia, identifying key health outcomes, vulnerable populations, and research and policy gaps.</p><p><strong>Methods: </strong>Following the PRISMA-ScR guidelines, a comprehensive search was conducted in PubMed, Scopus, Web of Science, and Google Scholar, as well as gray literature from WHO, UN agencies, and Somali institutions. Studies published between 1990 and 2025 in English and addressing the intersection of climate change and public health in Somalia or the Horn of Africa were included. Data were charted and synthesized thematically.</p><p><strong>Results: </strong>Out of 379 retrieved articles, 142 met the inclusion criteria. Key themes emerged: (1) direct health impacts of climate change, (2) indirect health impacts, (3) vulnerable populations, (4) weak health infrastructure and system readiness, and (5) historical droughts and their cumulative health impacts. Children under five, pregnant women, and displaced persons are disproportionately affected. The review highlights significant evidence gaps in mental health, health system resilience, and early warning systems.</p><p><strong>Conclusion: </strong>This scoping review highlights the severe and multifaceted public health impacts of climate change in Somalia, the fragile healthcare infrastructure in Somalia, and a heavy reliance on external aid. This review provides a foundation for future efforts to mitigate the public health impacts of climate change and build resilience in Somalia and similar vulnerable regions.</p>","PeriodicalId":23311,"journal":{"name":"Tropical Medicine and Health","volume":"53 1","pages":"193"},"PeriodicalIF":3.5,"publicationDate":"2025-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12739860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145828667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-24DOI: 10.1186/s41182-025-00854-x
Chuang Liu, Fang Wang, Zhen Zhang, Qiang Su, Yifeng Li
Background: While telomeres traditionally protect against cancer through genomic stability, recent evidence suggests a paradoxical association with increased malignancy risk. This study employed comprehensive Mendelian randomization (MR) to investigate the causal relationship between telomere length (TL) and colorectal cancer (CRC) risk and elucidate the underlying biological mechanisms through systematic mediation analysis.
Methods: We performed two-sample MR using genetic instruments from large-scale genome-wide association studies (GWASs). CRC data were obtained from FinnGen R12 (discovery cohort: 11,790 cases and 378,749 controls) and the GWAS Catalog (replication cohort: 19,948 cases and 12,124 controls). The inverse-variance weighted method served as the primary analysis, complemented by MR‒Egger, weighted median, and MR-PRESSO sensitivity analyses. The multivariable MR was adjusted for body mass index (BMI), processed meat intake, inflammatory bowel disease (IBD), and colorectal polyps. Two-step mediation analysis investigated 35 blood and urine biomarkers as potential mediators, with colocalization analysis performed to distinguish linkage from pleiotropy.
Results: Genetically predicted longer telomeres were consistently positively associated with increased CRC risk across both cohorts (discovery: odds ratio [OR] = 1.282, 95% confidence interval [CI] 1.126-1.459, P < 0.001; replication: OR = 1.253, 95% CI 1.067-1.472, P = 0.006). This association remained robust across multiple analytical methods and was independent of BMI, processed meat intake, IBD, and colorectal polyps. Mediation analysis revealed three significant mediators representing dual parallel mechanisms: insulin-like growth factor-1 (IGF-1) mediated 4.2% of the total effect through enhanced growth signaling (P = 0.0265), whereas total protein (TP) and nonalbumin protein (NAP) collectively mediated 19.67% through compromised protein homeostasis (10.33% and 9.34%, respectively; both P < 0.005). Colocalization analysis revealed the shared genetic architecture underlying these associations.
Conclusions: Longer telomeres causally increase CRC risk through dual parallel pathways: enhanced cellular proliferation via IGF-1 signaling and compromised immune surveillance through protein metabolic dysfunction. These findings challenge conventional protective roles attributed to telomeres and suggest that individuals with genetically longer telomeres may benefit from enhanced screening protocols and targeted interventions addressing both growth factor signaling and protein metabolic homeostasis.
{"title":"Telomere length promotes colorectal cancer through dual parallel pathways involving growth signaling and protein metabolism.","authors":"Chuang Liu, Fang Wang, Zhen Zhang, Qiang Su, Yifeng Li","doi":"10.1186/s41182-025-00854-x","DOIUrl":"10.1186/s41182-025-00854-x","url":null,"abstract":"<p><strong>Background: </strong>While telomeres traditionally protect against cancer through genomic stability, recent evidence suggests a paradoxical association with increased malignancy risk. This study employed comprehensive Mendelian randomization (MR) to investigate the causal relationship between telomere length (TL) and colorectal cancer (CRC) risk and elucidate the underlying biological mechanisms through systematic mediation analysis.</p><p><strong>Methods: </strong>We performed two-sample MR using genetic instruments from large-scale genome-wide association studies (GWASs). CRC data were obtained from FinnGen R12 (discovery cohort: 11,790 cases and 378,749 controls) and the GWAS Catalog (replication cohort: 19,948 cases and 12,124 controls). The inverse-variance weighted method served as the primary analysis, complemented by MR‒Egger, weighted median, and MR-PRESSO sensitivity analyses. The multivariable MR was adjusted for body mass index (BMI), processed meat intake, inflammatory bowel disease (IBD), and colorectal polyps. Two-step mediation analysis investigated 35 blood and urine biomarkers as potential mediators, with colocalization analysis performed to distinguish linkage from pleiotropy.</p><p><strong>Results: </strong>Genetically predicted longer telomeres were consistently positively associated with increased CRC risk across both cohorts (discovery: odds ratio [OR] = 1.282, 95% confidence interval [CI] 1.126-1.459, P < 0.001; replication: OR = 1.253, 95% CI 1.067-1.472, P = 0.006). This association remained robust across multiple analytical methods and was independent of BMI, processed meat intake, IBD, and colorectal polyps. Mediation analysis revealed three significant mediators representing dual parallel mechanisms: insulin-like growth factor-1 (IGF-1) mediated 4.2% of the total effect through enhanced growth signaling (P = 0.0265), whereas total protein (TP) and nonalbumin protein (NAP) collectively mediated 19.67% through compromised protein homeostasis (10.33% and 9.34%, respectively; both P < 0.005). Colocalization analysis revealed the shared genetic architecture underlying these associations.</p><p><strong>Conclusions: </strong>Longer telomeres causally increase CRC risk through dual parallel pathways: enhanced cellular proliferation via IGF-1 signaling and compromised immune surveillance through protein metabolic dysfunction. These findings challenge conventional protective roles attributed to telomeres and suggest that individuals with genetically longer telomeres may benefit from enhanced screening protocols and targeted interventions addressing both growth factor signaling and protein metabolic homeostasis.</p>","PeriodicalId":23311,"journal":{"name":"Tropical Medicine and Health","volume":"53 1","pages":"192"},"PeriodicalIF":3.5,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12729187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145828591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-21DOI: 10.1186/s41182-025-00882-7
Songling Hu, Bin Yang, Tian Yu, Can Wang, Ling Huang, Xiaofei Li, Liya Jiang, Qingling Hu, Jing Zhu
Background: Oral cancer including lip, oral cavity cancer contributes to cancer burden importantly in the world. It is crucial for effective policy planning to comprehensively evaluate oral cancer burden regionally.
Methods: The incidence, mortality, and disability-adjusted life years (DALYs) due to oral cancer from 1990 to 2021 were estimated according to Global Burden of Disease (GBD) 2021 methods. The GBD comparative risk assessment framework was used to estimate the proportion of deaths and DALYs for oral cancer attributable to smoking, tobacco, and alcohol consumption in 2021.
Results: The male-to-female ratio of age-standardized incidence rate (ASIR) for oral cancer was 2.99 in China, 2.7 in Europe, 2.24 in the United States, 1.73 in Southeast Asia, and 1.51 in Africa. The corresponding ratios of age-standardized mortality rate (ASMR) for oral cancer were 3.82, 3.16, 2.45, 1.89, and 1.60 respectively. Key risk factors for oral cancer-related deaths and DALYs varied by region and showed distinct age- and sex-stratified patterns. In China, tobacco was the primary contributor, accounting for 51.4% of oral cancer deaths in men, with a higher impact among older males aged ≥ 55 years. In Europe and the United States (US), alcohol consumption dominated, contributing a larger proportion of deaths in younger men (20-54 years) and showing higher attributable fractions than smoking in these age groups. In Southeast Asia, chewing tobacco was the major driver, responsible for 48.79% of oral cancer deaths in women, with this proportion exceeding 50% in females aged ≥ 55 years. Among men in Southeast Asia, smoking was the predominant risk factor for oral cancer mortality.
Conclusions: The burden of oral cancer exhibits distinct temporal and regional variations, with significant differences in incidence, mortality, and DALYs across global regions. Such differences are strongly associated with region-specific risk factor patterns, and these patterns also vary by age and sex. These insights highlight the need for targeted prevention strategies tailored to regional, age, and sex characteristics, including anti-smoking interventions in older Chinese men, alcohol control measures in younger European and American men, and efforts to reduce chewing tobacco use among older Southeast Asian women, to effectively mitigate the global burden of oral cancer.
{"title":"Comparative trends in oral cancer burden across the globe, China, Europe, the US, Southeast Asia, and Africa (1990-2021): a GBD 2021 analysis.","authors":"Songling Hu, Bin Yang, Tian Yu, Can Wang, Ling Huang, Xiaofei Li, Liya Jiang, Qingling Hu, Jing Zhu","doi":"10.1186/s41182-025-00882-7","DOIUrl":"10.1186/s41182-025-00882-7","url":null,"abstract":"<p><strong>Background: </strong>Oral cancer including lip, oral cavity cancer contributes to cancer burden importantly in the world. It is crucial for effective policy planning to comprehensively evaluate oral cancer burden regionally.</p><p><strong>Methods: </strong>The incidence, mortality, and disability-adjusted life years (DALYs) due to oral cancer from 1990 to 2021 were estimated according to Global Burden of Disease (GBD) 2021 methods. The GBD comparative risk assessment framework was used to estimate the proportion of deaths and DALYs for oral cancer attributable to smoking, tobacco, and alcohol consumption in 2021.</p><p><strong>Results: </strong>The male-to-female ratio of age-standardized incidence rate (ASIR) for oral cancer was 2.99 in China, 2.7 in Europe, 2.24 in the United States, 1.73 in Southeast Asia, and 1.51 in Africa. The corresponding ratios of age-standardized mortality rate (ASMR) for oral cancer were 3.82, 3.16, 2.45, 1.89, and 1.60 respectively. Key risk factors for oral cancer-related deaths and DALYs varied by region and showed distinct age- and sex-stratified patterns. In China, tobacco was the primary contributor, accounting for 51.4% of oral cancer deaths in men, with a higher impact among older males aged ≥ 55 years. In Europe and the United States (US), alcohol consumption dominated, contributing a larger proportion of deaths in younger men (20-54 years) and showing higher attributable fractions than smoking in these age groups. In Southeast Asia, chewing tobacco was the major driver, responsible for 48.79% of oral cancer deaths in women, with this proportion exceeding 50% in females aged ≥ 55 years. Among men in Southeast Asia, smoking was the predominant risk factor for oral cancer mortality.</p><p><strong>Conclusions: </strong>The burden of oral cancer exhibits distinct temporal and regional variations, with significant differences in incidence, mortality, and DALYs across global regions. Such differences are strongly associated with region-specific risk factor patterns, and these patterns also vary by age and sex. These insights highlight the need for targeted prevention strategies tailored to regional, age, and sex characteristics, including anti-smoking interventions in older Chinese men, alcohol control measures in younger European and American men, and efforts to reduce chewing tobacco use among older Southeast Asian women, to effectively mitigate the global burden of oral cancer.</p>","PeriodicalId":23311,"journal":{"name":"Tropical Medicine and Health","volume":" ","pages":"195"},"PeriodicalIF":3.5,"publicationDate":"2025-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12751674/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145805561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-19DOI: 10.1186/s41182-025-00859-6
Apsara S Babu, K V Bhaskara Rao
Background: Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis, remains a major public health challenge. The emergence of drug-resistant strains has further limited effective treatment options. Therefore, discovering novel antimycobacterial agents from underexplored habitats is essential. In this study, the marine actinobacterial extract Streptomyces qinglanensis VITABS23, isolated from mangrove sediments was evaluated for its antimycobacterial activity. The active protein was extracted and identified as a potential therapeutic candidate, and its toxicity profile was evaluated in animal models.
Methods: The cell-free extract of Streptomyces qinglanensis VITABS23 was screened for antimycobacterial activity against M. tuberculosis strains using agar well diffusion and microplate Alamar blue assays. Aqueous extracts were precipitated with 70% ammonium sulphate, dialyzed and purified by DEAE Sepharose ion exchange chromatography. The purified protein was characterized by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) and MALDI TOF analysis. For toxicity evaluation, in vivo studies were carried out in albino Wistar rats to determine the safety profile through acute (single doses of 100 and 350 mg/kg body weight) and sub-acute (repeated oral dosing) studies following OECD guideline 423. Body weights, hematological and biochemical parameters, and organ histopathology were assessed at the end of the experimental period.
Results: The extract showed maximum inhibition zones against M. smegmatis (26 mm) and M. tuberculosis H37Ra (22 mm) at 50 mg/ml. Minimum Inhibitory Concentration assays showed strong activity at a 500 µg/mL concentration, with 85% inhibition for M. tuberculosis H37Ra and 78% for M. smegmatis. Ion exchange chromatography yielded a 156-fold purification with a protein yield of 0.085% and a specific activity of 4166 IU/mg. The active protein had an intact molecular weight of 20 kDa. Acute toxicity studies showed no adverse effects at doses of 100 and 350 mg/kg body weight. Sub-acute studies with repeated dosing for 28 days revealed no mortality, toxic symptoms or significant differences compared with controls. Histopathological analysis of the vital organs in both studies revealed normal tissue architecture suggesting no morphological changes.
Conclusion: The S. qinglanensis VITABS23 extract from mangrove sediments demonstrates potent antimycobacterial activity and a favorable safety profile, highlighting its potential as a candidate for tuberculosis treatment.
{"title":"Investigation of the antimycobacterial potential and toxicity evaluation of a proteinaceous compound from Streptomyces qinglanensis VITABS23 against Mycobacterium tuberculosis strains.","authors":"Apsara S Babu, K V Bhaskara Rao","doi":"10.1186/s41182-025-00859-6","DOIUrl":"10.1186/s41182-025-00859-6","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis, remains a major public health challenge. The emergence of drug-resistant strains has further limited effective treatment options. Therefore, discovering novel antimycobacterial agents from underexplored habitats is essential. In this study, the marine actinobacterial extract Streptomyces qinglanensis VITABS23, isolated from mangrove sediments was evaluated for its antimycobacterial activity. The active protein was extracted and identified as a potential therapeutic candidate, and its toxicity profile was evaluated in animal models.</p><p><strong>Methods: </strong>The cell-free extract of Streptomyces qinglanensis VITABS23 was screened for antimycobacterial activity against M. tuberculosis strains using agar well diffusion and microplate Alamar blue assays. Aqueous extracts were precipitated with 70% ammonium sulphate, dialyzed and purified by DEAE Sepharose ion exchange chromatography. The purified protein was characterized by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) and MALDI TOF analysis. For toxicity evaluation, in vivo studies were carried out in albino Wistar rats to determine the safety profile through acute (single doses of 100 and 350 mg/kg body weight) and sub-acute (repeated oral dosing) studies following OECD guideline 423. Body weights, hematological and biochemical parameters, and organ histopathology were assessed at the end of the experimental period.</p><p><strong>Results: </strong>The extract showed maximum inhibition zones against M. smegmatis (26 mm) and M. tuberculosis H37Ra (22 mm) at 50 mg/ml. Minimum Inhibitory Concentration assays showed strong activity at a 500 µg/mL concentration, with 85% inhibition for M. tuberculosis H37Ra and 78% for M. smegmatis. Ion exchange chromatography yielded a 156-fold purification with a protein yield of 0.085% and a specific activity of 4166 IU/mg. The active protein had an intact molecular weight of 20 kDa. Acute toxicity studies showed no adverse effects at doses of 100 and 350 mg/kg body weight. Sub-acute studies with repeated dosing for 28 days revealed no mortality, toxic symptoms or significant differences compared with controls. Histopathological analysis of the vital organs in both studies revealed normal tissue architecture suggesting no morphological changes.</p><p><strong>Conclusion: </strong>The S. qinglanensis VITABS23 extract from mangrove sediments demonstrates potent antimycobacterial activity and a favorable safety profile, highlighting its potential as a candidate for tuberculosis treatment.</p>","PeriodicalId":23311,"journal":{"name":"Tropical Medicine and Health","volume":" ","pages":"191"},"PeriodicalIF":3.5,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12720479/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-19DOI: 10.1186/s41182-025-00884-5
Shuhang Luo, Shengjie Lin, Li Ma, Runhua Tang, Ying Song, Li Ma, Jianye Wang
Background: Insulin resistance (IR) is increasingly recognized as a significant factor for cancer development and progression. While the triglyceride-glucose (TyG) index and its derivatives (TyG-BMI (body mass index), TyG-WC (waist circumference), and TyG-WHtR (waist-to-height ratio)) have been developed as reliable and straightforward surrogate tools for reflecting IR status, their comparative associations with pan-cancer incidence and mortality remain unclear. This study aimed to systematically evaluate the associations of these four IR-related indices with pan-cancer incidence and cancer-specific mortality in a large prospective cohort.
Methods: This prospective cohort study analyzed data from 333,297 participants in the UK Biobank. The four IR-related indices mentioned above were calculated from baseline measurements. The primary outcomes were pan-cancer incidence and pan-cancer-specific mortality. Cox regression models, adjusted for demographic, socioeconomic, lifestyle, and clinical factors, were used to estimate hazard ratios (HRs) across participants' quartiles for each index. Besides, we assessed Dose-response relationships via restricted cubic splines (RCSs), and robustness via sensitivity and subgroup analyses.
Results: Over a median follow-up of 15.2 years, 49,695 cases of different types of cancer and 12,852 cancer-specific deaths were recorded. All four IR-related indices showed significant non-linear associations with both outcomes (p < 0.001). After full adjustment, TyG-WC demonstrated the strongest and most graded association with pan-cancer incidence, with HRs progressively increasing from Q2 to Q4 (all p < 0.05 vs. Q1), and HR of Q4 was 1.11 (95% CI (confidence interval): 1.08, 1.15, p = 0.001). For pan-cancer-specific mortality, TyG-WC (HR = 1.37, 95% CI 1.28, 1.46; p < 0.001), TyG-WHtR (HR = 1.25, 95% CI 1.18, 1.33; p < 0.001), and TyG-BMI (HR = 1.22, 95% CI 1.15,1.29; p < 0.001) were significantly elevated in Q4, with TyG-WC again showing a significant dose-response trend across all quartiles. In contrast, the original TyG index showed the weakest predictive performance. Subgroup analyses indicated effect modifications by sex, smoking status, and comorbidities. Sensitivity analyses confirmed the robustness of the associations, particularly for TyG-WC.
Conclusion: IR-related indices, especially TyG-WC, are significantly associated with both pan-cancer incidence and cancer-specific mortality. Compared with TyG, TyG-BMI, and TyG-WHtR, TyG-WC demonstrated stronger associations, suggesting its potential utility for stratifying cancer risk and prognosis in clinical and public health settings.
{"title":"Comprehensive evaluation of the prevalent insulin resistance indices for pan-cancer incidence and mortality prediction.","authors":"Shuhang Luo, Shengjie Lin, Li Ma, Runhua Tang, Ying Song, Li Ma, Jianye Wang","doi":"10.1186/s41182-025-00884-5","DOIUrl":"10.1186/s41182-025-00884-5","url":null,"abstract":"<p><strong>Background: </strong>Insulin resistance (IR) is increasingly recognized as a significant factor for cancer development and progression. While the triglyceride-glucose (TyG) index and its derivatives (TyG-BMI (body mass index), TyG-WC (waist circumference), and TyG-WHtR (waist-to-height ratio)) have been developed as reliable and straightforward surrogate tools for reflecting IR status, their comparative associations with pan-cancer incidence and mortality remain unclear. This study aimed to systematically evaluate the associations of these four IR-related indices with pan-cancer incidence and cancer-specific mortality in a large prospective cohort.</p><p><strong>Methods: </strong>This prospective cohort study analyzed data from 333,297 participants in the UK Biobank. The four IR-related indices mentioned above were calculated from baseline measurements. The primary outcomes were pan-cancer incidence and pan-cancer-specific mortality. Cox regression models, adjusted for demographic, socioeconomic, lifestyle, and clinical factors, were used to estimate hazard ratios (HRs) across participants' quartiles for each index. Besides, we assessed Dose-response relationships via restricted cubic splines (RCSs), and robustness via sensitivity and subgroup analyses.</p><p><strong>Results: </strong>Over a median follow-up of 15.2 years, 49,695 cases of different types of cancer and 12,852 cancer-specific deaths were recorded. All four IR-related indices showed significant non-linear associations with both outcomes (p < 0.001). After full adjustment, TyG-WC demonstrated the strongest and most graded association with pan-cancer incidence, with HRs progressively increasing from Q2 to Q4 (all p < 0.05 vs. Q1), and HR of Q4 was 1.11 (95% CI (confidence interval): 1.08, 1.15, p = 0.001). For pan-cancer-specific mortality, TyG-WC (HR = 1.37, 95% CI 1.28, 1.46; p < 0.001), TyG-WHtR (HR = 1.25, 95% CI 1.18, 1.33; p < 0.001), and TyG-BMI (HR = 1.22, 95% CI 1.15,1.29; p < 0.001) were significantly elevated in Q4, with TyG-WC again showing a significant dose-response trend across all quartiles. In contrast, the original TyG index showed the weakest predictive performance. Subgroup analyses indicated effect modifications by sex, smoking status, and comorbidities. Sensitivity analyses confirmed the robustness of the associations, particularly for TyG-WC.</p><p><strong>Conclusion: </strong>IR-related indices, especially TyG-WC, are significantly associated with both pan-cancer incidence and cancer-specific mortality. Compared with TyG, TyG-BMI, and TyG-WHtR, TyG-WC demonstrated stronger associations, suggesting its potential utility for stratifying cancer risk and prognosis in clinical and public health settings.</p>","PeriodicalId":23311,"journal":{"name":"Tropical Medicine and Health","volume":" ","pages":"9"},"PeriodicalIF":3.5,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12781529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145794995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-19DOI: 10.1186/s41182-025-00878-3
Maria Fe R Cruz, Chris Smith, Kensuke Takahashi, Su Myat Han, Jeffrey A Verona
Background: Tetanus remains a rare but potentially fatal disease, typically associated with traumatic wounds. However, necrotic malignancies such as fungating breast tumors may also serve as an entry point for Clostridium tetani infection.
Case presentation: We report the case of a 58-year-old female with a 3-year history of a fungating left breast mass who presented with trismus. A diagnosis of tetanus was made clinically. The patient received treatment with anti-tetanus globulin, metronidazole, and she was placed in a dark room with sound insulation and shielding. The surgical team was consulted for wound management. However, in accordance with the patient's refusal, surgical debridement was not performed. Instead, local wound cleansing and supportive management were initiated.
Conclusions: Tetanus should be considered in patients with necrotic tumors presenting with trismus, especially in low-resource settings where immunization histories are uncertain. Early intervention is crucial to reduce morbidity and prevent complications.
{"title":"Clinically diagnosed tetanus in a 58-year-old female with breast fungating mass.","authors":"Maria Fe R Cruz, Chris Smith, Kensuke Takahashi, Su Myat Han, Jeffrey A Verona","doi":"10.1186/s41182-025-00878-3","DOIUrl":"10.1186/s41182-025-00878-3","url":null,"abstract":"<p><strong>Background: </strong>Tetanus remains a rare but potentially fatal disease, typically associated with traumatic wounds. However, necrotic malignancies such as fungating breast tumors may also serve as an entry point for Clostridium tetani infection.</p><p><strong>Case presentation: </strong>We report the case of a 58-year-old female with a 3-year history of a fungating left breast mass who presented with trismus. A diagnosis of tetanus was made clinically. The patient received treatment with anti-tetanus globulin, metronidazole, and she was placed in a dark room with sound insulation and shielding. The surgical team was consulted for wound management. However, in accordance with the patient's refusal, surgical debridement was not performed. Instead, local wound cleansing and supportive management were initiated.</p><p><strong>Conclusions: </strong>Tetanus should be considered in patients with necrotic tumors presenting with trismus, especially in low-resource settings where immunization histories are uncertain. Early intervention is crucial to reduce morbidity and prevent complications.</p>","PeriodicalId":23311,"journal":{"name":"Tropical Medicine and Health","volume":" ","pages":"8"},"PeriodicalIF":3.5,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12781299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-19DOI: 10.1186/s41182-025-00866-7
Francisca S Y Wong, Fukushi Morishita, Kyung Hyun Oh, Huong Thi Giang Tran, Rajendra-Prasad Yadav
Background: Migration significantly influences tuberculosis (TB) epidemiology in the Western Pacific Region (WPR), posing challenges to its control and elimination. This study examines the burden of TB among foreign-born individuals at regional and national levels in the WPR.
Methods: Using data from the WHO Global TB Database and the United Nations' International Migrant Stock dataset, we analysed the number and proportion of foreign-born TB case notifications across the region from 2008 to 2023. We also compared estimated TB incidence among international migrants with regional and national averages in WPR destinations.
Results: Foreign-born TB notifications increased from 5,639 in 2008 to 10,056 in 2023, with trends varying across the WPR. Malaysia (40.4%), Japan (16.0%), and Australia (12.7%) accounted for the largest caseloads in 2023. Between 2021 and 2023, foreign-born TB cases represented 0.8% of total case notifications in the region, with Australia (89.9%), and New Zealand (86.5%) reporting the highest proportions. As of 2020, international migrants in the WPR (24.8 million, 77.9% of whom originated from high-burden countries) had an estimated TB incidence rate of 130 per 100,000, exceeding national averages in many countries and areas.
Conclusions: Significant disparities remain in the foreign-born TB burden across the WPR. Strengthening surveillance, improving data comparability, and enhancing cross-border collaboration through migrant-sensitive approaches may help address existing gaps and support progress towards the End TB targets.
{"title":"Tuberculosis among foreign-born populations in the Western Pacific Region: emerging trends and analysis from 2008 to 2023.","authors":"Francisca S Y Wong, Fukushi Morishita, Kyung Hyun Oh, Huong Thi Giang Tran, Rajendra-Prasad Yadav","doi":"10.1186/s41182-025-00866-7","DOIUrl":"10.1186/s41182-025-00866-7","url":null,"abstract":"<p><strong>Background: </strong>Migration significantly influences tuberculosis (TB) epidemiology in the Western Pacific Region (WPR), posing challenges to its control and elimination. This study examines the burden of TB among foreign-born individuals at regional and national levels in the WPR.</p><p><strong>Methods: </strong>Using data from the WHO Global TB Database and the United Nations' International Migrant Stock dataset, we analysed the number and proportion of foreign-born TB case notifications across the region from 2008 to 2023. We also compared estimated TB incidence among international migrants with regional and national averages in WPR destinations.</p><p><strong>Results: </strong>Foreign-born TB notifications increased from 5,639 in 2008 to 10,056 in 2023, with trends varying across the WPR. Malaysia (40.4%), Japan (16.0%), and Australia (12.7%) accounted for the largest caseloads in 2023. Between 2021 and 2023, foreign-born TB cases represented 0.8% of total case notifications in the region, with Australia (89.9%), and New Zealand (86.5%) reporting the highest proportions. As of 2020, international migrants in the WPR (24.8 million, 77.9% of whom originated from high-burden countries) had an estimated TB incidence rate of 130 per 100,000, exceeding national averages in many countries and areas.</p><p><strong>Conclusions: </strong>Significant disparities remain in the foreign-born TB burden across the WPR. Strengthening surveillance, improving data comparability, and enhancing cross-border collaboration through migrant-sensitive approaches may help address existing gaps and support progress towards the End TB targets.</p>","PeriodicalId":23311,"journal":{"name":"Tropical Medicine and Health","volume":"53 1","pages":"190"},"PeriodicalIF":3.5,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145795076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-16DOI: 10.1186/s41182-025-00872-9
Kashf Younas, Raghabendra Kumar Mahato
This Matters Arising article provides a methodological commentary on the recent study by Rivadeneira et al. concerning the impact of hepatic cystic echinococcosis (HCE) recurrence on postoperative outcomes. While acknowledging the importance of their findings from an endemic region of Chile, we aim to critically examine key methodological aspects to clarify the independent prognostic role of recurrence. We discuss considerations including potential residual confounding from unadjusted cyst characteristics and surgical variables, the ascertainment of recurrence based on imaging, and the generalizability of the results from a high-endemicity population. The core purpose is to build upon this valuable work by proposing methodological refinements for future research. We recommend multi-center studies, standardized outcome sets, and combined follow-up protocols to precisely quantify the burden of HCE recurrence and enhance the global applicability of the findings for improved clinical guidelines.
{"title":"Refining the prognostic understanding of recurrence in hepatic cystic echinococcosis surgery: a matters arising perspective.","authors":"Kashf Younas, Raghabendra Kumar Mahato","doi":"10.1186/s41182-025-00872-9","DOIUrl":"10.1186/s41182-025-00872-9","url":null,"abstract":"<p><p>This Matters Arising article provides a methodological commentary on the recent study by Rivadeneira et al. concerning the impact of hepatic cystic echinococcosis (HCE) recurrence on postoperative outcomes. While acknowledging the importance of their findings from an endemic region of Chile, we aim to critically examine key methodological aspects to clarify the independent prognostic role of recurrence. We discuss considerations including potential residual confounding from unadjusted cyst characteristics and surgical variables, the ascertainment of recurrence based on imaging, and the generalizability of the results from a high-endemicity population. The core purpose is to build upon this valuable work by proposing methodological refinements for future research. We recommend multi-center studies, standardized outcome sets, and combined follow-up protocols to precisely quantify the burden of HCE recurrence and enhance the global applicability of the findings for improved clinical guidelines.</p>","PeriodicalId":23311,"journal":{"name":"Tropical Medicine and Health","volume":"53 1","pages":"188"},"PeriodicalIF":3.5,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12706934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145763956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-16DOI: 10.1186/s41182-025-00850-1
Tu Quyen Tran Lam, Yu-Chia Hsieh, Thi Tuyet-Anh Nguyen, I-Hsin Sung, Shiao-Wen Li, Yi-Jiun Pan
Background: Acinetobacter baumannii has emerged as a significant global pathogen, and community-acquired infections are concerning due to their severe clinical outcomes and high mortality. Despite this, the molecular epidemiology and phenotypic characteristics of community-acquired/community-onset A. baumannii (CAAB/COAB) strains remain poorly understood. This study analyzed the genotypes, virulence traits, and clinical manifestations of 32 COAB isolates collected in Taiwan between 2015 and 2017.
Methods: Capsular types (KLs), sequence types (STs) from the Oxford and Pasteur schemes, and international clones (ICs) were identified among the 32 COAB isolates. In vitro virulence was assessed by evaluating biofilm formation, motility, resistance to desiccation and serum, and in vivo virulence was confirmed in a Galleria mellonella larvae model. Associations between KL/ST types and virulence phenotypes, as well as between KL/ST types and the clinical manifestations of patients, were also analyzed.
Results: The results showed that among the tested COAB isolates, KL49 was the predominant capsular type, representing 18.8% (n = 6) of samples, and ST10Pas/IC8 (ST10Pas: ST10 under the Pasteur scheme, IC8: international clone 8) was the major clone (15.6%, n = 5). Interestingly, we found that KL49/ST10Pas, which is predominant in America and Australia but has never been reported for CAAB/COAB in Taiwan, had a hypervirulent phenotype with high serum resistance and high mortality in the G. mellonella larvae model. Furthermore, clinical records showed higher incidences of chronic obstructive pulmonary disease, pneumonia, elevated Pitt bacteremia scores, and 30-day mortality for patients with KL49/ST10Pas infections than for patients with non-KL49/ST10Pas infections.
Conclusions: This is the first report identifying KL49/ST10Pas as a major clone of COAB in Taiwan. Its high virulence was demonstrated, highlighting a potential public health threat. This study lays a foundation for understanding the molecular epidemiology of COAB in Taiwan and supports future research on virulence and disease control strategies.
{"title":"Emerging virulent clones of community-onset Acinetobacter baumannii in Taiwan.","authors":"Tu Quyen Tran Lam, Yu-Chia Hsieh, Thi Tuyet-Anh Nguyen, I-Hsin Sung, Shiao-Wen Li, Yi-Jiun Pan","doi":"10.1186/s41182-025-00850-1","DOIUrl":"10.1186/s41182-025-00850-1","url":null,"abstract":"<p><strong>Background: </strong>Acinetobacter baumannii has emerged as a significant global pathogen, and community-acquired infections are concerning due to their severe clinical outcomes and high mortality. Despite this, the molecular epidemiology and phenotypic characteristics of community-acquired/community-onset A. baumannii (CAAB/COAB) strains remain poorly understood. This study analyzed the genotypes, virulence traits, and clinical manifestations of 32 COAB isolates collected in Taiwan between 2015 and 2017.</p><p><strong>Methods: </strong>Capsular types (KLs), sequence types (STs) from the Oxford and Pasteur schemes, and international clones (ICs) were identified among the 32 COAB isolates. In vitro virulence was assessed by evaluating biofilm formation, motility, resistance to desiccation and serum, and in vivo virulence was confirmed in a Galleria mellonella larvae model. Associations between KL/ST types and virulence phenotypes, as well as between KL/ST types and the clinical manifestations of patients, were also analyzed.</p><p><strong>Results: </strong>The results showed that among the tested COAB isolates, KL49 was the predominant capsular type, representing 18.8% (n = 6) of samples, and ST10<sup>Pas</sup>/IC8 (ST10<sup>Pas</sup>: ST10 under the Pasteur scheme, IC8: international clone 8) was the major clone (15.6%, n = 5). Interestingly, we found that KL49/ST10<sup>Pas</sup>, which is predominant in America and Australia but has never been reported for CAAB/COAB in Taiwan, had a hypervirulent phenotype with high serum resistance and high mortality in the G. mellonella larvae model. Furthermore, clinical records showed higher incidences of chronic obstructive pulmonary disease, pneumonia, elevated Pitt bacteremia scores, and 30-day mortality for patients with KL49/ST10<sup>Pas</sup> infections than for patients with non-KL49/ST10<sup>Pas</sup> infections.</p><p><strong>Conclusions: </strong>This is the first report identifying KL49/ST10<sup>Pas</sup> as a major clone of COAB in Taiwan. Its high virulence was demonstrated, highlighting a potential public health threat. This study lays a foundation for understanding the molecular epidemiology of COAB in Taiwan and supports future research on virulence and disease control strategies.</p>","PeriodicalId":23311,"journal":{"name":"Tropical Medicine and Health","volume":"53 1","pages":"189"},"PeriodicalIF":3.5,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145769106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}